DOCSLIB.ORG

ASCI / AAP Joint Meeting 2015 April 24 – 26, 2015 the Fairmont Chicago Chicago, Illinois

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ASCI / AAP Joint Meeting 2015 April 24 – 26, 2015 the Fairmont Chicago Chicago, Illinois Meeting Program and Abstracts ASCI / AAP Joint Meeting 2015 April 24 – 26, 2015 The Fairmont Chicago Chicago, Illinois www.jointmeeting.org The ASCI / AAP conference is jointly provided by Boston University School of Medicine and ASCI / AAP. www.jointmeeting.org Special Events at the 2015 ASCI/AAP Joint Meeting Friday, April 24 Saturday, April 25 ASCI President’s Reception ASCI Reception for New Members (Invitation only) and Young Physician-Scientist 6:15 – 7:15 p.m. Poster Session Gold Room (Invited guests and members of the ASCI and AAP only) 6:00 – 8:00 p.m. ASCI Annual Dinner & Gold Room New Member Induction Ceremony Speaker: Griffin P. Rodgers, MD, MACP (Ticketed guests only) National Institute of Diabetes, Digestive and 7:30 – 9:45 p.m. Kidney Diseases Moulin Rouge, 1st Floor Inspiring the Next Generation of Physician-Scientists AAP Annual Reception & Dinner Speaker: Robert J. Lefkowitz, MD 7:00 – 10:00 p.m. Duke University Imperial Ballroom From Lake Wobegon to Stockholm AAP President’s Dinner Speaker: Peter Agre, MD (Invitation only) Johns Hopkins University 7:00 – 9:00 p.m. (Off site) APSA Dinner 7:30 – 9:00 p.m. APSA Welcome Reception & Moulin Rouge Presidential Address Life as a Physician-Scientist: The Road from Here to 9:00 p.m. – Midnight There and Everywhere John Hancock Center (Off site) Speaker: Liise-anne Pirofski, MD Albert Einstein College of Medicine Speaker: Michael Guo APSA President Dessert Reception (Open to all attendees) 10:00 p.m. – Midnight Imperial Foyer www.jointmeeting.org 2 www.jointmeeting.org General Information Accreditation and Learning Objectives Credit Designation As a result of this meeting, participants will be able to: This activity has been planned and implemented in accordance • Discuss important recent advances in the scientific basis of with the Essential Areas and Policies of the Accreditation Council disease and therapy for Continuing Medical Education (ACCME) through the joint • Describe novel strategies to address challenges to the providership of the Boston University School of Medicine, the physician-scientist American Society for Clinical Investigation and the Association • Evaluate the roles that improved understanding of these of American Physicians. Boston University School of Medicine advances and strategies can play in the potential treatment of is accredited by the ACCME to provide continuing medical human disease education for physicians. Boston University School of Medicine designates this live activity for a maximum of 9 AMA PRA Category 1 Credits™. Physicians Target Audience should claim only the credit commensurate with the extent of Any physician-scientists, trainees, and students, across a their participation in the activity. broad range of specialties (Basic Research, Cardiology / Nurses and other health professionals will receive a Certificate Cardiovascular Research, Cell and Molecular Biology, Endocrine of Attendance. For information on applicability and acceptance, and Metabolism, Hematology, Immunology, Infectious Diseases, please consult your professional licensing board. Nephrology, Neurology, Pulmonology, others. Course Director Educational Need Edward Alexander, MD The Joint Meeting Planning Committee strives to represent Boston University School of Medicine the cutting edge of biomedical research and medicine. The Committee is especially interested in identifying gaps in knowledge that may exist in the target audience, which consists Program Planning Committee of physician-scientists, research scientists, clinicians and medical education professionals. The meeting also targets junior Committee Members: scientists and trainees, who benefit from close interaction with Paul Rothman, MD — AAP President senior colleagues. Johns Hopkins University The 2015 ASCI/AAP Joint Meeting program will feature lectures Stanley Lemon, MD — AAP President-Elect by accomplished researchers who will discuss state-of-the-art The University of North Carolina at Chapel Hill advances in their respective fields. The program is designed to foster in-depth discussions and close interactions among the Christine E. Seidman, MD — AAP Vice President meeting participants. Brigham and Women’s Hospital — Harvard Medical School DISCLAIMER: THESE MATERIALS AND ALL OTHER MATERIALS J. Larry Jameson, MD, PhD — AAP Immediate Past President PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL University of Pennsylvania Health System, Perelman School EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR of Medicine PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL Mukesh K. Jain, MD — ASCI President EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE Case Western Reserve University School of Medicine PROFESSIONALS. ANYONE USING THE MATERIALS Levi Garraway, MD, PhD — ASCI President-Elect ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR Harvard Medical School, Dana-Farber Cancer Institute APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS Peter Tontonoz, MD, PhD — ASCI Immediate Past President WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, University of California, Los Angeles, David Geffen School CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR of Medicine FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE Lori Ennis — Executive Director AAP, LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION Ex Officio Committee Member TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS John Hawley — Executive Director ASCI, A SUBSTITUTE FOR PROFESSIONAL CARE. Ex Officio Committee Member 3 www.jointmeeting.org General Information Full Disclosure Policy Affecting Disclosure of Unlabeled/ CME Activities Investigational Uses of Drugs Boston University School of Medicine asks all individuals or Devices involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships None of the faculty has indicated that they plan to discuss with commercial interests. This information is disclosed to CME unlabeled or investigational uses of products or devices. activity participants. Boston University School of Medicine has procedures to resolve any apparent conflicts of interest. In addition, faculty members are asked to disclose when any 2015 Joint Meeting Program unapproved use of pharmaceuticals and devices is being discussed. It is understood that presentations must give a Committee Disclosures balanced view of therapeutic options. Faculty use of generic The following program committee members indicated that they names will contribute to this impartiality. The speaker will have financial relationships to disclose. They have agreed to make every effort to ensure that data regarding the company’s disclose this to participants. All other named program committee products (or competing products) are objectively selected and members in this program have completed financial disclosure presented, with balanced discussion of prevailing information on forms and had no financial relationships to report. the product(s) and/or alternative treatments. First Last Disclosure Levi Garraway Foundation Medicine: co-founder, stockholder, and 2015 Joint Meeting Faculty consultant (myself) Novartis: sponsored research support and consultant (myself) Boehringer Disclosures Ingelheim: consultant (myself) The following faculty indicated that they have financial Paul Rothman Board Member Cancer Genetics Inc. relationships to disclose. They have agreed to disclose this Christine Seidman CES is a founder and owns shares in Myokardia to participants. All other named faculty in this program have Inc., a startup company that is developing completed financial disclosure forms and had no financial therapeutics that target the sarcomere. relationships to report. First Last Disclosure Richard Ehman President, CEO, equity holder, in Resoundant, Inc. Claiming CME Credit Jeffrey Friedman I am listed on the leptin patent and receive a portion Participants who wish to claim CME credit will receive a CME of the royalties Credit Claim Form and a Required Evaluation with conference Daniel Geschwind Consultant, Medical Advisory Board Novartis materials. In order to claim credit, these forms must be Consultant Advisory Board SynapDx completed and returned to the conference registration desk Gail Hecht Dannon - Scientific Advisory Board member or mailed to: Attention Erika Moy, The Kellen Company, Rudolf Jaenisch Fate Therapeutics - consultant Stemgent - consultant 111 Deer Lake Road, Deerfield, IL 60015 no later than May 25, 2015, in order to receive credit. Jeffrey Kline Consultant-- Janssen Pharma Grant support--NIH Consultant--Stago Diagnostica Mitchell Lazar Eli Lilly and Company (Board Member) Pfizer Inc. (Board Member) KDAC Therapeutics, Inc (Board Member) Janssen (Consultant) Merck Inc. (Grant Support) Jeffrey Leiden 1. Vertex Pharmaceuticals, Inc. - Chairman, CEO, President & shareholder 2. Quest Diagnostics - Director, shareholder 3. Claurs Ventures - Former Managing Director, Senior Advisor Stanley Lemon Merck - Consultant, research support AbbVie - Consultant, other Theravance - Consultant Alfred Sommer Just finished being a Director of Becton Dickenson. My “retirement” payout will span 10 years Craig Thompson Board of Directors: Merck, Charles River Laboratories, NY Genome Center; SAB/stock holder- Agios; CEO- MSKCC; SAB- MDA, City of Hope Victor Velculescu 1. Personal Genome Diagnostics (PGDx) : Founder/ BOD/Officer - Shareholder 2. Quintiles : Member of Sci. Ad. Board - Honorarium 4
Load more

Recommended publications
  • Unrestricted Immigration and the Foreign Dominance Of
    Unrestricted Immigration and the Foreign Dominance of United States Nobel Prize Winners in Science: Irrefutable Data and Exemplary Family Narratives—Backup Data and Information Andrew A. Beveridge, Queens and Graduate Center CUNY and Social Explorer, Inc. Lynn Caporale, Strategic Scientific Advisor and Author The following slides were presented at the recent meeting of the American Association for the Advancement of Science. This project and paper is an outgrowth of that session, and will combine qualitative data on Nobel Prize Winners family histories along with analyses of the pattern of Nobel Winners. The first set of slides show some of the patterns so far found, and will be augmented for the formal paper. The second set of slides shows some examples of the Nobel families. The authors a developing a systematic data base of Nobel Winners (mainly US), their careers and their family histories. This turned out to be much more challenging than expected, since many winners do not emphasize their family origins in their own biographies or autobiographies or other commentary. Dr. Caporale has reached out to some laureates or their families to elicit that information. We plan to systematically compare the laureates to the population in the US at large, including immigrants and non‐immigrants at various periods. Outline of Presentation • A preliminary examination of the 609 Nobel Prize Winners, 291 of whom were at an American Institution when they received the Nobel in physics, chemistry or physiology and medicine • Will look at patterns of
    [Show full text]
  • Peter Agre, 2003 Nobel Prize Winner in Chemistry
    SPECIAL COMMENTARY J Am Soc Nephrol 15: 1093–1095, 2004 Peter Agre, 2003 Nobel Prize Winner in Chemistry MARK A. KNEPPER,* and SOREN NIELSEN† National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland; and †Water and Salt Research Center, University of Aarhus, Aarhus, Denmark. Abstract. Peter C. Agre, an American Society of Nephrology somes after the incorporation of the purified protein. These member, is the recipient of the 2003 Nobel Prize in Chemistry findings sparked a veritable explosion of work that affects for his discovery of the aquaporin water channels. The function several long-standing areas of investigation such as the bio- of many cells requires that water move rapidly into and out of physics of water permeation across cell membranes, the struc- them. There was only indirect evidence that proteinaceous tural biology of integral membrane proteins, the physiology of channels provide this vital activity until Agre and colleagues fluid transport in the kidney and other organs, and the patho- purified aquaporin-1 from human erythrocytes and reported its physiological basis of inherited and acquired disorders of water cDNA sequence. They proved that aquaporin-1 is a specific balance. Agre’s discovery of the first water channel has water channel by cRNA expression studies in Xenopus oocytes spurred a revolution in animal and plant physiology and in and by functional reconstitution of transport activity in lipo- medicine. American Society of Nephrology member, Peter Agre of ing duct, revealed that the increase in water permeability was Johns Hopkins University, received the 2003 Nobel Prize in associated with the appearance of membrane particle aggre- Chemistry for his discovery of the aquaporins, a family of gates in the apical plasma membrane.
    [Show full text]
  • Channel Hoppers Land Chemistry Nobel Jim Giles Two Structural Biologists Credited With
    news Channel hoppers land chemistry Nobel Jim Giles Two structural biologists credited with A. ABBOTT transforming our understanding of how cells work have been awarded the 2003 R. BOREA/AP Nobel Prize in Chemistry. Peter Agre of Johns Hopkins University in Baltimore and Roderick MacKinnon of the Rockefeller University in New York share the prize for experiments that revealed the intri- cate workings of the channels that allow ions and water to enter and leave cells. MacKinnon is perhaps the most widely tipped Nobel winner of recent years.In a land- mark 1998 paper (D. A. Doyle et al. Science 280, 69–77; 1998), he and his colleagues pro- vided the first detailed three-dimensional Roderick MacKinnon (left) and Peter Agre’s work on cell-membrane proteins has won them recognition. picture of a protein that acts as a channel to control the flow of potassium ions across cell deserved a Nobel.“His work is a tour de force,” Kuhajda and P. Agre J. Biol. Chem. 263, membranes. This channel is immensely says John Walker, a structural biologist at the 15634–15642; 1988). “No one had seen it important to neuroscientists, as the flow of University of Cambridge, UK. “The award is before,but we found that it was the fifth most potassium ions helps to generate the voltage absolutely spot on and richly deserved.” abundant protein in the cell,” says Agre. pulses that brain cells use to communicate. MacKinnon was on holiday when the “That’s like coming across a big town that’s Before MacKinnon’s paper, many biolo- prize was announced, and couldn’t be not on the map.It gets your attention.” gists had questioned whether the technique informed directly by the Nobel prize com- The protein, now known as aquaporin 1, he used — X-ray crystallography — could be mittee.
    [Show full text]
  • Nobel Laureates Endorse Joe Biden
    Nobel Laureates endorse Joe Biden 81 American Nobel Laureates in Physics, Chemistry, and Medicine have signed this letter to express their support for former Vice President Joe Biden in the 2020 election for President of the United States. At no time in our nation’s history has there been a greater need for our leaders to appreciate the value of science in formulating public policy. During his long record of public service, Joe Biden has consistently demonstrated his willingness to listen to experts, his understanding of the value of international collaboration in research, and his respect for the contribution that immigrants make to the intellectual life of our country. As American citizens and as scientists, we wholeheartedly endorse Joe Biden for President. Name Category Prize Year Peter Agre Chemistry 2003 Sidney Altman Chemistry 1989 Frances H. Arnold Chemistry 2018 Paul Berg Chemistry 1980 Thomas R. Cech Chemistry 1989 Martin Chalfie Chemistry 2008 Elias James Corey Chemistry 1990 Joachim Frank Chemistry 2017 Walter Gilbert Chemistry 1980 John B. Goodenough Chemistry 2019 Alan Heeger Chemistry 2000 Dudley R. Herschbach Chemistry 1986 Roald Hoffmann Chemistry 1981 Brian K. Kobilka Chemistry 2012 Roger D. Kornberg Chemistry 2006 Robert J. Lefkowitz Chemistry 2012 Roderick MacKinnon Chemistry 2003 Paul L. Modrich Chemistry 2015 William E. Moerner Chemistry 2014 Mario J. Molina Chemistry 1995 Richard R. Schrock Chemistry 2005 K. Barry Sharpless Chemistry 2001 Sir James Fraser Stoddart Chemistry 2016 M. Stanley Whittingham Chemistry 2019 James P. Allison Medicine 2018 Richard Axel Medicine 2004 David Baltimore Medicine 1975 J. Michael Bishop Medicine 1989 Elizabeth H. Blackburn Medicine 2009 Michael S.
    [Show full text]
  • Nobel Week Stockholm 2018 – Detailed Information for the Media
    Nobel Week Stockholm • 2018 Detailed information for the media December 5, 2018 Content The 2018 Nobel Laureates 3 The 2018 Nobel Week 6 Press Conferences 6 Nobel Lectures 8 Nobel Prize Concert 9 Nobel Day at the Nobel Museum 9 Nobel Week Dialogue – Water Matters 10 The Nobel Prize Award Ceremony in Stockholm 12 Presentation Speeches 12 Musical Interludes 13 This Year’s Floral Decorations, Concert Hall 13 The Nobel Banquet in Stockholm 14 Divertissement 16 This Year’s Floral Decorations, City Hall 20 Speeches of Thanks 20 End of the Evening 20 Nobel Diplomas and Medals 21 Previous Nobel Laureates 21 The Nobel Week Concludes 22 Follow the Nobel Prize 24 The Nobel Prize Digital Channels 24 Nobelprize org 24 Broadcasts on SVT 25 International Distribution of the Programmes 25 The Nobel Museum and the Nobel Center 25 Historical Background 27 Preliminary Timetable for the 2018 Nobel Prize Award Ceremony 30 Seating Plan on the Stage, 2018 Nobel Prize Award Ceremony 32 Preliminary Time Schedule for the 2018 Nobel Banquet 34 Seating Plan for the 2018 Nobel Banquet, City Hall 35 Contact Details 36 the nobel prize 2 press MeMo 2018 The 2018 Nobel Laureates The 2018 Laureates are 12 in number, including Denis Mukwege and Nadia Murad, who have been awarded the Nobel Peace Prize Since 1901, the Nobel Prize has been awarded 590 times to 935 Laureates Because some have been awarded the prize twice, a total of 904 individuals and 24 organisations have received a Nobel Prize or the Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel
    [Show full text]
  • 2016 Annual Report
    2015–2016 Annual Report A Year of Results A MESSAGE FROM BOTTOM LINE LEADERSHIP Dear Friends, We are proud to share Bottom Line’s 2016 Annual Report with you. The following pages highlight the work that Bottom Line focuses on, day after day, month after month. You will meet a few of our students that are the heart of this organization. You will see the incredible results of last year’s programming. Finally, you will see our strong financial position—and how we make this all possible—through a diverse community of supporters like you. In many ways, our 2016 fiscal year was a pivotal one for Bottom Line. • Our largest group of students, 1,289 in total, entered our Success Program and, at the same time, we saw 334 students graduate from college, up 35% over last year. • We provided college advising and coaching to almost 5,000 students. Virgil J. Jones, Jr. • 79% of our students graduated from college—a rate more than four times the national average of low-income, first-generation students. • We also approved a 5-year strategic plan, establishing our commitment to measured growth in our current regions as well as the expansion to new sites. • We have strengthened our executive staff and our board with seasoned professionals to lead our growth and expansion. These are milestones along a journey and direction that has made this one of the most successful years in Bottom Line’s history. Our commitment to our students graduating from college ready for a career, demonstrated by our high-touch and one-on-one counseling for up to 7 years of our students’ journeys towards their degrees, still drives our programs.
    [Show full text]
  • Duke University 2000-2002
    bulletin of Duke University 2000-2002 The Graduate School The Mission of Duke University The founding Indenture of Duke University directed the members of the university to "develop our resources, increase our wisdom, and promote human happiness." To these ends, the mission of Duke University is to provide a superior liberal education to undergraduate students, attending not only to their intellectual growth but also to their development as adults committed to high ethical standards and full participation as leaders in their communities; to prepare future members of the learned professions for lives of skilled and ethical service by providing excellent graduate and professional education; to advance the frontiers of knowledge and contribute boldly to the international community of scholarship; to foster health and well-being through medical research and patient care; and to promote a sincere spirit of tolerance, a sense of the obligations and rewards of citizenship, and a commitment to learning, freedom, and truth. By pursuing these objectives with vision and integrity, Duke University seeks to engage the mind, elevate the spirit, and stimulate the best effort of all who are associated with the university; to contribute in diverse ways to the local community, the state, the nation, and the world; and to attain and maintain a place of real leadership in all that we do. ACADEMIC LIAISON Leigh DeNeef Associate Dean EDITOR Judith Smith PUBLICATIONS COORDINATOR Mary Nettleton STAFF SPECIALIST: COURSE CATALOG MASTER Margaret R. Sims PHOTOGRAPHS University Photography The information in the bulletin applies to the academic years 2000-2002 and is accurate and current, to the best of our knowledge, as of May 2000.
    [Show full text]
  • COMMENTARY Does Transcription by RNA Polymerase Play a Direct Role in the Initiation of Replication?
    Journal of Cell Science 107, 1381-1387 (1994) 1381 Printed in Great Britain © The Company of Biologists Limited 1994 COMMENTARY Does transcription by RNA polymerase play a direct role in the initiation of replication? A. Bassim Hassan* and Peter R. Cook† CRC Nuclear Structure and Function Research Group, Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, UK *Present address: Addenbrooke’s NHS Trust, Hills Rd, Cambridge CB2 2QQ, UK †Author for correspondence SUMMARY RNA polymerases have been implicated in the initiation of replication in bacteria. The conflicting evidence for a role in initiation in eukaryotes is reviewed. Key words: cell cycle, initiation, origin, replication, transcription PRIMERS AND PRIMASES complex becomes exclusively involved in the synthesis of Okazaki fragments on the lagging strand. A critical step in this DNA polymerases cannot initiate the synthesis of new DNA process is the unwinding of the duplex. chains, they can only elongate pre-existing primers. The opposite polarities of the two strands of the double helix coupled with the 5′r3′ polarity of the polymerase means that RNA POLYMERASES AND THE INITIATION OF replication occurs relatively continuously on one (leading) REPLICATION IN BACTERIA strand and discontinuously on the other (lagging) strand. The continuous strand probably needs to be primed once, usually The first evidence of a role for RNA polymerase came from at an origin. Nature has found many different ways of doing the demonstration that the initiation of replication in this, including the use of RNA primers made by an RNA poly- Escherichia coli was sensitive to rifampicin, an inhibitor of merase (e.g.
    [Show full text]
  • Antibiotic Resistance by High-Level Intrinsic Suppression of a Frameshift Mutation in an Essential Gene
    Antibiotic resistance by high-level intrinsic suppression of a frameshift mutation in an essential gene Douglas L. Husebya, Gerrit Brandisa, Lisa Praski Alzrigata, and Diarmaid Hughesa,1 aDepartment of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University, Uppsala SE-751 23, Sweden Edited by Sankar Adhya, National Institutes of Health, National Cancer Institute, Bethesda, MD, and approved January 4, 2020 (received for review November 5, 2019) A fundamental feature of life is that ribosomes read the genetic (unlikely if the DNA sequence analysis was done properly), that the code in messenger RNA (mRNA) as triplets of nucleotides in a mutants carry frameshift suppressor mutations (15–17), or that the single reading frame. Mutations that shift the reading frame gen- mRNA contains sequence elements that promote a high level of ri- erally cause gene inactivation and in essential genes cause loss of bosomal shifting into the correct reading frame to support cell viability viability. Here we report and characterize a +1-nt frameshift mutation, (10). Interest in understanding these mutations goes beyond Mtb and centrally located in rpoB, an essential gene encoding the beta-subunit concerns more generally the potential for rescue of mutants that ac- of RNA polymerase. Mutant Escherichia coli carrying this mutation are quire a frameshift mutation in any essential gene. We addressed this viable and highly resistant to rifampicin. Genetic and proteomic exper- by isolating a mutant of Escherichia coli carrying a frameshift mutation iments reveal a very high rate (5%) of spontaneous frameshift suppres- in rpoB and experimentally dissecting its genotype and phenotypes. sion occurring on a heptanucleotide sequence downstream of the mutation.
    [Show full text]
  • 2008 Notice of Meeting
    Intentionally left blank Notice of the 2008 Annual General Meeting and accompanying notes This document is important and requires your immediate attention. If you are in any doubt as to the action you should take, you should consult an independent adviser authorised under the Financial Services and Markets Act 2000 if you are in the United Kingdom, or from another appropriately authorised independent adviser if you are in a territory outside the United Kingdom. If you have transferred or sold all of your shares in the Company, please send this document and the accompanying proxy appointment form to the transferee or to the agent through whom you acted for forwarding to the transferee. A personalised proxy appointment form for use by holders of ordinary shares in the Company has been despatched with this notice. A separate instruction card for holders of American Depositary Receipts to give instructions to the Depositary for the American Depositary Shares in the Company is being provided to such holders. So that effective use may be made of the proxy form, your attention is drawn to the notes to the notice contained in this document and to the instructions on the form. Shire Limited (Incorporated and registered in Jersey No. 99854) 22 August 2008 To Shareholders Notice of Annual General Meeting Dear Shareholder, I am pleased to be writing to you with details of our Annual General Meeting (“AGM”) which we are holding at the Merrion Hotel, Upper Merrion Street, Dublin 2, Ireland on 24 September 2008 at 12:00 noon. The formal Notice of AGM is set out on pages 03 and 04 of this document.
    [Show full text]
  • Resistance to Rifampicin: a Review
    The Journal of Antibiotics (2014) 67, 625–630 & 2014 Japan Antibiotics Research Association All rights reserved 0021-8820/14 www.nature.com/ja REVIEW ARTICLE Resistance to rifampicin: a review Beth P Goldstein Resistance to rifampicin (RIF) is a broad subject covering not just the mechanism of clinical resistance, nearly always due to a genetic change in the b subunit of bacterial RNA polymerase (RNAP), but also how studies of resistant polymerases have helped us understand the structure of the enzyme, the intricacies of the transcription process and its role in complex physiological pathways. This review can only scratch the surface of these phenomena. The identification, in strains of Escherichia coli, of the positions within b of the mutations determining resistance is discussed in some detail, as are mutations in organisms that are therapeutic targets of RIF, in particular Mycobacterium tuberculosis. Interestingly, changes in the same three codons of the consensus sequence occur repeatedly in unrelated RIF-resistant (RIFr) clinical isolates of several different bacterial species, and a single mutation predominates in mycobacteria. The utilization of our knowledge of these mutations to develop rapid screening tests for detecting resistance is briefly discussed. Cross-resistance among rifamycins has been a topic of controversy; current thinking is that there is no difference in the susceptibility of RNAP mutants to RIF, rifapentine and rifabutin. Also summarized are intrinsic RIF resistance and other resistance mechanisms. The Journal of Antibiotics (2014) 67, 625–630; doi:10.1038/ja.2014.107; published online 13 August 2014 INTRODUCTION laboratory studies and emerging in patients who received mono- In celebrating the life of Professor Piero Sensi and his discovery of therapy with RIF.
    [Show full text]
  • Los Premios Nobel De Química
    Los premios Nobel de Química MATERIAL RECOPILADO POR: DULCE MARÍA DE ANDRÉS CABRERIZO Los premios Nobel de Química El campo de la Química que más premios ha recibido es el de la Quí- mica Orgánica. Frederick Sanger es el único laurea- do que ganó el premio en dos oca- siones, en 1958 y 1980. Otros dos también ganaron premios Nobel en otros campos: Marie Curie (física en El Premio Nobel de Química es entregado anual- 1903, química en 1911) y Linus Carl mente por la Academia Sueca a científicos que so- bresalen por sus contribuciones en el campo de la Pauling (química en 1954, paz en Física. 1962). Seis mujeres han ganado el Es uno de los cinco premios Nobel establecidos en premio: Marie Curie, Irène Joliot- el testamento de Alfred Nobel, en 1895, y que son dados a todos aquellos individuos que realizan Curie (1935), Dorothy Crowfoot Ho- contribuciones notables en la Química, la Física, la dgkin (1964), Ada Yonath (2009) y Literatura, la Paz y la Fisiología o Medicina. Emmanuelle Charpentier y Jennifer Según el testamento de Nobel, este reconocimien- to es administrado directamente por la Fundación Doudna (2020) Nobel y concedido por un comité conformado por Ha habido ocho años en los que no cinco miembros que son elegidos por la Real Aca- demia Sueca de las Ciencias. se entregó el premio Nobel de Quí- El primer Premio Nobel de Química fue otorgado mica, en algunas ocasiones por de- en 1901 al holandés Jacobus Henricus van't Hoff. clararse desierto y en otras por la Cada destinatario recibe una medalla, un diploma y situación de guerra mundial y el exi- un premio económico que ha variado a lo largo de los años.
    [Show full text]